Lingvay I, Cheng AY, Levine JA, Gomez-Valderas E, Allen SE, Ranta K, Torcello-Gomez A, Thieu VT (2023) Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: a post hoc analysis of the SURPASS-1 to -5 studies
Personally, I wouldnt start on anything over 0.50 mg/week as a beginner
GLP-1 medications generally do not produce these psychological effects, though the rapid change in relationship with food can create its own psychological adjustment
Incapsula incident ID: 641000740050392777-206449336974906001
Eine bewusste Dosierung ist der Schlssel zur sicheren Nutzung
A patient expecting a 5mg vial receives a 10mg vial, adds 2 mL as instructed for 5mg, and creates a 5 mg/mL solution instead of 2.5 mg/mL